Enzyre Projects

Enzyre - BioChip

Biochip project

Service facility

Enzyre BV

Transistorweg 5-i
6534-AT Nijmegen
The Netherlands

Enzyre (founded in 2016) will drive point of diagnostics to its top. Enzyres mission is to develop innovative diagnostic solutions enabling personalized medicine. 

  • Enzyre Nijmegen The Netherlands
  • Signing building contract

Signing building contract

News February 14th, 2018 - Nijmegen (NL)
On February 14th CSO Waander van Heerde from Enzyre signs a new lease contract with Pim van Os, commercial manager of Kadans Science partner for office and laboratory space in Building M of the Novio Tech Campus. The campus is situated on former NXP terrain. Building M is a state-of-the art research and production facility for companies active in life science, healthcare and semiconductors.
  • First Multisensor Wafer Biochip
  • First Multisensor Biochip Wafer

Receiving the first multisensor wafer

News February 1st, 2018 - Nijmegen (NL)
February 1st CSO Waander van Heerde from Enzyre received the first multisensor NXP wafer from Frank Wennekes, process development / program manager of NXP. This wafer contains an optical sensor, one of the key elements for the integrated microfluidic cartridge for the Enzyre biochip platform. The optical sensors will be used in combination with Enzyres proprietary chemiluminescence technology to measure enzymatic reactions.

Two day bootcamp design Biochip

News January 25th, 2018 - Nijmegen (NL)
From March 25th – 26th Enzyre organised a two day bootcamp in Hotel Ruimzicht (Doetinchem, NL) with our collaborating partners EPR Partner, Micronit, Sencio and Fuse Design Consultants to draw up and refine the design of the biochip. Next steps were made to create a cheap, simple, small and applicable design for point of care disease management with personalized medicine.
Company
  • Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken.
Enzyre BV
  • Transistorweg 5
  • 6534-AT Nijmegen
  • The Netherlands
  • Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken.
Follow us